Search

everythinglearnresearchcommunity

for

Search:↓

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

Hair loss is linked to higher prostate-specific antigen levels and urinary symptoms, likely due to age.

Six new genetic regions linked to early hair loss also connect to Parkinson's disease and prostate cancer, possibly leading to new treatments.

11α-Hydroxyprogesterone is changed into different substances by certain enzymes and may play a role in prostate cancer.

5α-reductase inhibitors, like finasteride and dutasteride, effectively treat BPH, male baldness, and hirsutism, with potential for acne and prostate cancer prevention.

The link between anabolic agents and colorectal cancer risk is unclear.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Epitestosterone may counteract testosterone's effects and has roles in body processes like prostate growth and hair distribution.

Both estrogens and androgens are important for health in both males and females.

SARMs show promise but need more evidence to prove they're better than traditional androgens.

Androgens increase muscle mass by promoting myoblast growth through ornithine decarboxylase.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.

PAK4 is crucial in cancer progression, brain development, and could be a therapeutic target, especially through the PAK4-CREB axis.

SGK1 is important in cancer growth and treatment resistance, and targeting it could improve therapies.

Blocking androgen receptors boosts macrophages' ability to clear certain bacteria.

Finasteride treats enlarged prostate, improves urinary flow, but may cause sexual side effects.

Certain drugs increase calcium levels in cancer cells by triggering internal calcium release.

Prostaglandins and the enzyme AKR1C3 could play a role in skin cancer and hair loss, and further research is needed to understand these mechanisms.

PROTACs show promise for cancer treatment, but designing them effectively is challenging.

Finasteride effectively treats hair loss and enlarged prostate in men, with mild side effects.

Testosterone boosts red blood cell production and changes iron metabolism without needing dihydrotestosterone.

New compounds were made that block an enzyme linked to breast cancer better than existing treatments.

Finasteride is effective for hair loss and prostate issues but may cause lasting side effects.

Normal levels of DHT can reduce belly fat and increase muscle, but too much can lead to hair loss, prostate issues, and possibly heart disease.

Dihydrotestosterone increases growth and spread of human brain cancer cells, and blocking its formation might help treat this cancer.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

People with early hair loss may have a higher chance of enlarged prostate and metabolic syndrome, so they should be checked for urinary and metabolic issues.

Wnt signaling is important for development and cell regulation but can cause diseases like cancer when not working properly.